Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1547716

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1547716

Global Oncology Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

PUBLISHED:
PAGES: 128 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3920
PDF (10-user License)
USD 4730
PDF (Corporate User License)
USD 7430

Add to Cart

The global demand for Oncology Drugs Market is presumed to reach the market size of nearly USD 351.1 Billion by 2032 from USD 178.44 Billion in 2023 with a CAGR of 7.81% under the study period 2024-2032.

Oncology drugs refer to medications used for cancer treatment. A drug used in cancer treatment varies in structure and mechanism of action. It kills cancer cells, stops them from growing and spreading to other parts of the body, helps the body regain strength, and develop new healthy cells. It also treats symptoms that cancer causes, like pain. With advances in understanding cancer biology, better treatment options, including drugs, are being devised, leading to new products approval and launch.

MARKET DYNAMICS

The growing burden of cancer diseases drives the growth of the global oncology drugs market. According to the World Health Organization estimates, the worldwide cancer burden is assessed to have ascended to 18.1 million new cases, and 9.6 million passings in 2018. It is projected that by 2030 between 10 and 11 million cancers will be diagnosed each year in low- and middle-income countries. The expanding disease burden is because of a few elements, including the aging population, changing lifestyle, among others. The growing approval for new drugs by the FDA and rising penetration of health insurance is amplifying revenue growth. Malignant of the lung, female breast, and colorectum are the top three cancers in terms of incidence, estimated to hold the majority share in global terms. However, expensive treatment and limited treatment options restrain the growth of the market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oncology Drugs. The growth and trends of Oncology Drugs industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Oncology Drugs market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapeutic Modals

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy
  • Hormonal Therapy
  • Others

By Cancer Type

  • Breast Cancer
  • Blood Cancer
  • Prostate Cancer
  • Skin Cancer
  • Lung Cancer
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oncology Drugs market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oncology Drugs market include Johnson & Johnson, Amgen Inc., Eli Lilly & Co., GlaxoSmithKline, Roche Diagnostics, Merck & Co., Pfizer, Sanofi, Celgene Corporation, Novartis AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11213665

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ONCOLOGY DRUGS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Therapeutic Modals
    • 3.7.2 Market Attractiveness Analysis By Cancer Type
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY THERAPEUTIC MODALS

  • 5.1. Overview By Therapeutic Modals
  • 5.2. Historical and Forecast Data Analysis By Therapeutic Modals
  • 5.3. Chemotherapy Historic and Forecast Sales By Regions
  • 5.4. Targeted Therapy Historic and Forecast Sales By Regions
  • 5.5. Immunotherapy Historic and Forecast Sales By Regions
  • 5.6. Hormonal Therapy Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY CANCER TYPE

  • 6.1. Overview By Cancer Type
  • 6.2. Historical and Forecast Data Analysis By Cancer Type
  • 6.3. Breast Cancer Historic and Forecast Sales By Regions
  • 6.4. Blood Cancer Historic and Forecast Sales By Regions
  • 6.5. Prostate Cancer Historic and Forecast Sales By Regions
  • 6.6. Skin Cancer Historic and Forecast Sales By Regions
  • 6.7. Lung Cancer Historic and Forecast Sales By Regions
  • 6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL ONCOLOGY DRUGS MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE ONCOLOGY DRUGS COMPANIES

  • 8.1. Oncology Drugs Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF ONCOLOGY DRUGS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Johnson & Johnson
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Amgen Inc.
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Eli Lilly & Co.
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. GlaxoSmithKline
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Roche Diagnostics
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. Merck & Co.
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Pfizer
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Sanofi
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. Celgene Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Novartis AG
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

Product Code: VMR11213665

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Therapeutic Modals (USD MN)
  • Chemotherapy Market Sales By Geography (USD MN)
  • Targeted Therapy Market Sales By Geography (USD MN)
  • Immunotherapy Market Sales By Geography (USD MN)
  • Hormonal Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Cancer Type (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Blood Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Skin Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Oncology Drugs Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oncology Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Oncology Drugs Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Therapeutic Modals
  • Market Attractiveness Analysis By Cancer Type
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Therapeutic Modals (USD MN)
  • Chemotherapy Market Sales By Geography (USD MN)
  • Targeted Therapy Market Sales By Geography (USD MN)
  • Immunotherapy Market Sales By Geography (USD MN)
  • Hormonal Therapy Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Cancer Type (USD MN)
  • Breast Cancer Market Sales By Geography (USD MN)
  • Blood Cancer Market Sales By Geography (USD MN)
  • Prostate Cancer Market Sales By Geography (USD MN)
  • Skin Cancer Market Sales By Geography (USD MN)
  • Lung Cancer Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!